MiniMed's Model 508
This article was originally published in The Gray Sheet
Executive Summary
Next-generation insulin infusion pump for diabetics, introduced Oct. 4, offers remote programming capabilities to administer or suspend insulin delivery and the capability to program multiple patient-specific delivery patterns. The device gained FDA 510(k) clearance in June
You may also be interested in...
MiniMed Continuous Glucose Monitor Rollout Expanding To 30 Centers In Q4
Expanded roll-out of MiniMed's continuous glucose monitor system to twenty-one additional U.S. centers will be completed by the end of November, the firm says.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.